Physician profile
Swaraj Bose
NPI 1285714360
$29,236.78
in general payments reported to CMS, 2019-2025
11 companies · $743 in 2025
The $743 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,053 · 2020: $1,015 · 2021: $5,220 · 2022: $16K · 2023: $1,184 · 2024: $512 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504 · Honoraria: $800 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.45 |
| Honoraria | $800.00 |
| Education | $135.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $27,467.02 | 2019-2023 | Tepezza, Uplizna |
| Amgen INC. | $648.22 | 2024-2025 | Tepezza, Uplizna |
| Alexion Pharmaceuticals, INC. | $589.45 | 2020-2025 | Ultomiris, Soliris |
| Argenx US, INC. | $147.39 | 2022-2024 | Vyvgart, Vyvgart Hytrulo |
| Csl Behring | $127.78 | 2025 | Hizentra |
| Dompe US, INC. | $112.26 | 2022-2024 | Oxervate |
| Allergan, INC. | $71.66 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $23.65 | 2019 | |
| Ani Pharmaceuticals, INC. | $17.13 | 2024 | Purified Cortrophin Gel |
| Sun Pharmaceutical Industries INC. | $16.51 | 2020 | |
| Oyster Point Pharma, INC. | $15.71 | 2025 | Ryzumvi, Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swaraj Bose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.